NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2024 - 2025)

NovaBridge Biosciences (NBP) posted quarterly Amortizatization of Intangibles of $201000.0 for Q4 2025, up 5.24% year-on-year from $191000.0 in Q4 2024, and up 1.01% on a QoQ basis from $199000.0 in Q3 2025.

NovaBridge Biosciences (NBP) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Amortizatization of Intangibles for 2 consecutive years, with $201000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 5.24% year-over-year to $201000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $767000.0 (changed N/A YoY) and the FY2025 annual result came in at $788000.0, up 9.9% from the prior year.
  • Amortizatization of Intangibles improved to $201000.0 in Q4 2025 per NBP's latest filing, from $199000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for NBP reached as high as $201000.0 in Q4 2025 and fell as low as $176000.0 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 NovaBridge Biosciences 397.57 Mn 397.57 Mn - 201,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 201,000.00
Dec 31, 2025 201,000.00
Sep 30, 2025 199,000.00
Sep 30, 2025 199,000.00
Dec 31, 2024 191,000.00
Dec 31, 2024 191,000.00
Sep 30, 2024 176,000.00
Sep 30, 2024 176,000.00